PL376413A1 - Preparat farmaceutyczny olanzapiny - Google Patents

Preparat farmaceutyczny olanzapiny

Info

Publication number: PL376413A1
Authority: PL; Poland
Prior art keywords: olanzapine; pharmaceutical formulation; monosaccharide; oligosaccharide; polysaccharide
Prior art date: 2002-10-18

Application number

PL03376413A

Other languages

English (en)

Other versions

PL206217B1 (pl

Inventor

Stanka Perc

Ivanka Banko

Ivanka Kolenc

Original Assignee

Krka Tovarna Zdravil, D.D, Novo Mesto

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-18

Filing date

2003-10-16

Publication date

2005-12-27

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32173824&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL376413(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-10-16 Application filed by Krka Tovarna Zdravil, D.D, Novo Mesto filed Critical Krka Tovarna Zdravil, D.D, Novo Mesto

2005-12-27 Publication of PL376413A1 publication Critical patent/PL376413A1/pl

2010-07-30 Publication of PL206217B1 publication Critical patent/PL206217B1/pl

Links

KVWDHTXUZHCGIO-UHFFFAOYSA-N olanzapine Chemical compound C1CN(C)CCN1C1=NC2=CC=CC=C2NC2=C1C=C(C)S2 KVWDHTXUZHCGIO-UHFFFAOYSA-N 0.000 title abstract 2
229960005017 olanzapine Drugs 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title abstract 2
239000004480 active ingredient Substances 0.000 abstract 1
150000004676 glycans Chemical class 0.000 abstract 1
239000008240 homogeneous mixture Substances 0.000 abstract 1
239000004615 ingredient Substances 0.000 abstract 1
150000002772 monosaccharides Chemical class 0.000 abstract 1
229920001542 oligosaccharide Polymers 0.000 abstract 1
150000002482 oligosaccharides Chemical class 0.000 abstract 1
229920001282 polysaccharide Polymers 0.000 abstract 1
239000005017 polysaccharide Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Biophysics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Molecular Biology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

PL376413A 2002-10-18 2003-10-16 Preparat farmaceutyczny olanzapiny i sposób wytwarzania preparatu PL206217B1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SI200200255A SI21303A (sl)	2002-10-18	2002-10-18	Farmacevtska formulacija olanzapina

Publications (2)

Publication Number	Publication Date
PL376413A1 true PL376413A1 (pl)	2005-12-27
PL206217B1 PL206217B1 (pl)	2010-07-30

Family

ID=32173824

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL376413A PL206217B1 (pl)	2002-10-18	2003-10-16	Preparat farmaceutyczny olanzapiny i sposób wytwarzania preparatu

Country Status (18)

Country	Link
US (2)	US20050288276A1 (pl)
EP (1)	EP1558219B1 (pl)
AT (1)	ATE374600T1 (pl)
AU (1)	AU2003269792A1 (pl)
CA (1)	CA2502582C (pl)
CY (1)	CY1107819T1 (pl)
DE (1)	DE60316714T2 (pl)
DK (1)	DK1558219T3 (pl)
EA (1)	EA008516B1 (pl)
ES (1)	ES2295626T3 (pl)
HR (1)	HRP20050342B1 (pl)
NO (1)	NO20052408L (pl)
PL (1)	PL206217B1 (pl)
PT (1)	PT1558219E (pl)
RS (1)	RS51488B (pl)
SI (2)	SI21303A (pl)
UA (1)	UA89349C2 (pl)
WO (1)	WO2004035027A1 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2006018318A1 (en) *	2004-08-18	2006-02-23	Synthon B.V.	Liquid paroxetine compositions
CZ297214B6 (cs) *	2005-02-02	2006-10-11	Zentiva, A. S.	Lécivý prípravek obsahující jako úcinnou slozku olanzapin a zpusob jeho výroby
GB0522473D0 (en) *	2005-11-03	2005-12-14	Actavis Group	A pharmaceutical formulation
GB0522474D0 (en) *	2005-11-03	2005-12-14	Actavis Group	A pharmaceutical formulation
ES2279715B1 (es)	2005-12-26	2008-06-01	Laboratorios Lesvi, S.L.	Formulacion oral de olanzapina.
US20070293479A1 (en) *	2006-05-18	2007-12-20	Osinga Niels J	Olanzapine pharmaceutical composition
US20080138409A1 (en) *	2006-09-29	2008-06-12	Osinga Niels J	Olanzapine pharmaceutical composition
WO2012014012A1 (es) *	2010-07-27	2012-02-02	Laboratorios Andrómaco S.A.	Procedimiento para preparar comprimidos de disolucion rapida oral que comprenden la forma i de olanzapina, los comprimidos obtenidos y su uso para el tratamiento de la esquizofrenia.
WO2012153347A2 (en)	2011-05-04	2012-11-15	Zentiva K.S.	Oral pharmaceutical composition of olanzapine form 1
WO2013066280A1 (en) *	2011-10-31	2013-05-10	Mahmut Bilgic	Water soluble antipsychotic formulations
CN103919782B (zh) *	2013-01-15	2016-12-28	天津药物研究院有限公司	一种含有奥氮平的药物组合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2115116C3 (de) *	1970-03-27	1982-04-15	Sankyo Co., Ltd., Tokyo	Gleitmittel und Verfahren zu dessen Herstellung
US5229382A (en) *	1990-04-25	1993-07-20	Lilly Industries Limited	2-methyl-thieno-benzodiazepine
GB9009229D0 (en)	1990-04-25	1990-06-20	Lilly Industries Ltd	Pharmaceutical compounds
CN1230883A (zh) *	1996-09-24	1999-10-06	伊莱利利公司	包衣颗粒制剂
US6348458B1 (en) *	1999-12-28	2002-02-19	U & I Pharmaceuticals Ltd.	Polymorphic forms of olanzapine
JP4530664B2 (ja) *	2001-12-24	2010-08-25	サン・ファーマシューティカル・インダストリーズ・リミテッド	２−メチル−４−（４−メチル−１−ピペラジニル）−１０Ｈ−チエノ［２，３−ｂ］［１，５］ベンゾジアゼピンの結晶形Ｉ、この結晶形Ｉの製造方法、及び医薬組成物
AU2002255196A1 (en) *	2002-04-18	2003-10-27	Dr. Reddy's Laboratories Ltd.	Rapidly dispersing solid oral compositions

2002
- 2002-10-18 SI SI200200255A patent/SI21303A/sl not_active IP Right Cessation
2003
- 2003-10-16 WO PCT/SI2003/000036 patent/WO2004035027A1/en not_active Ceased
- 2003-10-16 HR HRP20050342AA patent/HRP20050342B1/hr not_active IP Right Cessation
- 2003-10-16 AT AT03751723T patent/ATE374600T1/de active
- 2003-10-16 PL PL376413A patent/PL206217B1/pl unknown
- 2003-10-16 US US10/531,540 patent/US20050288276A1/en not_active Abandoned
- 2003-10-16 EP EP03751723A patent/EP1558219B1/en not_active Revoked
- 2003-10-16 AU AU2003269792A patent/AU2003269792A1/en not_active Abandoned
- 2003-10-16 PT PT03751723T patent/PT1558219E/pt unknown
- 2003-10-16 ES ES03751723T patent/ES2295626T3/es not_active Expired - Lifetime
- 2003-10-16 DK DK03751723T patent/DK1558219T3/da active
- 2003-10-16 SI SI200331001T patent/SI1558219T1/sl unknown
- 2003-10-16 DE DE60316714T patent/DE60316714T2/de not_active Expired - Lifetime
- 2003-10-16 EA EA200500671A patent/EA008516B1/ru not_active IP Right Cessation
- 2003-10-16 CA CA2502582A patent/CA2502582C/en not_active Expired - Fee Related
- 2003-10-16 UA UAA200504641A patent/UA89349C2/uk unknown
- 2003-10-16 RS YUP-2005/0292A patent/RS51488B/sr unknown
2005
- 2005-05-13 NO NO20052408A patent/NO20052408L/no not_active Application Discontinuation
2007
- 2007-12-03 CY CY20071101537T patent/CY1107819T1/el unknown
2011
- 2011-09-08 US US13/228,028 patent/US20110319395A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20110319395A1 (en)	2011-12-29
ATE374600T1 (de)	2007-10-15
HRP20050342A2 (hr)	2006-04-30
SI1558219T1 (sl)	2008-02-29
RS51488B (sr)	2011-04-30
DK1558219T3 (da)	2007-10-29
AU2003269792A1 (en)	2004-05-04
RS20050292A (sr)	2007-08-03
NO20052408D0 (no)	2005-05-13
SI21303A (sl)	2004-04-30
EA008516B1 (ru)	2007-06-29
PT1558219E (pt)	2008-01-04
EP1558219B1 (en)	2007-10-03
CA2502582C (en)	2010-08-03
WO2004035027A1 (en)	2004-04-29
HRP20050342B1 (hr)	2013-11-08
US20050288276A1 (en)	2005-12-29
CA2502582A1 (en)	2004-04-29
EA200500671A1 (ru)	2005-10-27
PL206217B1 (pl)	2010-07-30
EP1558219A1 (en)	2005-08-03
UA89349C2 (uk)	2010-01-25
NO20052408L (no)	2005-07-04
ES2295626T3 (es)	2008-04-16
DE60316714T2 (de)	2008-07-17
DE60316714D1 (de)	2007-11-15
CY1107819T1 (el)	2013-06-19

Publication	Publication Date	Title
CY1107819T1 (el)	2013-06-19	Φαρμακευτικη διαμορφωση της ολανζαπινης
NO2025027I1 (no)	2025-06-13	Pharmaceutical mixture or association that includes as active ingredients: (1) ceftazidime or a salt thereof, and (2) avibactam or a pharmaceutically acceptable salt thereof - forlenget.
EP1589947B8 (en)	2016-08-24	Pharmaceutical formulation with an insoluble active agent for pulmonary administration
WO2005041925A3 (en)	2005-09-29	Compositions and dosage forms for enhanced absorption
AU2003274681A1 (en)	2004-02-23	Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release
BE2011C013I2 (pl)	2019-10-16
AU2001296865A1 (en)	2002-03-22	(5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
EP2308479A3 (en)	2012-10-24	Compounds and compositions for delivering active agents
HRP20040849A2 (en)	2005-08-31	Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
ATE292453T1 (de)	2005-04-15	Antivirale arznei
MXPA03008420A (es)	2004-03-16	Forma farmaceutica solida oralmente dispersa.
WO2002015959A3 (en)	2002-08-22	Compounds and compositions for delivering active agents
WO2005065639A3 (en)	2005-09-01	Novel pharmaceutical compositions
WO2002015933A3 (en)	2003-08-14	Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser
WO2004069187A3 (en)	2005-03-31	Drug formulation and delivery using crystalline methylated cyclodextrins
AU2001260089A1 (en)	2001-12-03	Pharmaceutical compositions comprising desglymidodrine as an active drug substance
EP1273301A3 (en)	2003-04-09	Pharmaceutical preparations based on active ingredients susceptible to illict administration
IL166596A0 (en)	2006-01-15	Salt of morphine-6-glucoronide
WO2002041875A3 (de)	2002-11-14	Verfahren zur herstellung leicht löslicher arzneimittelformulierungen und entsprechende formulierungen
PL375503A1 (pl)	2005-11-28	Kompozycja farmaceutyczna zawierająca antagonistęLTB4 i inhibitor COX-2 albo łączony inhibitor COX1/2
WO2000051603A3 (en)	2001-01-11	Compositions of remifentanil
WO2002072016A3 (en)	2003-02-13	Method of preventing adhesions with ifn-¿y?
HK1088213A (en)	2006-11-03	Pharmaceutical formulation with an insoluble active agent for pulmonary administration
IL163552A0 (en)	2005-12-18	Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof